HubSpot vs. Salesforce: Which CRM Stock Is the Better Buy?

Salesforce is framed as the more defensive pick versus HubSpot on valuation: CRM trades at a 17.7x P/E versus HUBS’s 95.1x, while both firms are gaining traction in agentic AI. Salesforce’s Agentforce annual recurring revenue reached $1.2B (+205% YoY) and it posts a higher net profit margin (19% in fiscal 2027 Q1) than HubSpot’s 3.7% net margin in calendar Q1, despite HubSpot’s faster revenue growth (23% vs Salesforce’s 14%). Overall, the article suggests the “SaaSpocalypse” fears look overstated, but HubSpot’s lofty valuation leaves it more exposed if growth slows.

Analysis

The market is still conflating “AI disruption” with “software obsolescence,” but the more likely near-term outcome is platform consolidation: large incumbents that already control workflows will use agentic layers to raise switching costs and bundle more value into existing contracts. That favors CRM over higher-multiple point-growth names because the AI upgrade path is easier to monetize from a large installed base, while also giving management a stronger case for price increases and multi-product adoption. In contrast, HUBS needs both continued top-line acceleration and meaningful margin inflection to justify its premium multiple; absent that, the stock remains highly duration-sensitive to any growth deceleration.

The key second-order effect is not just incremental AI revenue, but procurement behavior. If buyers believe one vendor can now cover more tasks end-to-end, they are likelier to consolidate spend into the dominant suite and delay smaller add-on tools. That is constructive for CRM, mildly negative for adjacent SaaS names that sell narrow workflow modules, and potentially positive for services partners that implement these stacks. Over 1-3 months, earnings prints matter more than product launches: investors will look for proof that AI is improving net retention, attach rates, and gross margin rather than just creating narrative lift.

Contrarian view: the consensus may be underestimating how much of the recent de-rating was justified for HUBS, since a 90+ multiple leaves almost no room for execution misses or macro softness. Conversely, CRM may be underappreciated because its lower multiple and larger base make AI monetization look slower on a percentage basis even if it is more durable in dollar terms. The thesis breaks if HUBS shows sustained reacceleration with 200-300bps margin expansion, or if CRM’s remaining performance obligations and AI attach rates stop compounding over the next two quarters.

Key Decisions for Investors

• Long CRM / short HUBS as a relative-value pair for the next 1-2 earnings cycles: CRM has better downside support from valuation and a more visible AI monetization path; HUBS needs perfect execution to defend its multiple.
• If wanting directional exposure, prefer CRM over HUBS on any 5-10% pullback: the risk/reward is better because CRM can re-rate modestly on evidence of AI-driven upsell, while HUBS is more vulnerable to multiple compression if growth normalizes.
• Buy HUBS only as a tactical momentum trade after a confirmed acceleration in billings or margin guidance; otherwise treat it as a watchlist name, not a core long, given the elevated valuation and limited margin of safety.
• Monitor CRM quarterly for AI attach-rate and cRPO/RPO growth; if those metrics stall for two prints, reduce exposure or pair it against the software ETF (IGV) to isolate idiosyncratic risk.
• For investors wanting a cleaner AI-enablement basket, accumulate CRM on weakness rather than chasing high-beta SaaS, since the first beneficiaries are likely to be incumbents with distribution and workflow control.